Login Register Cart 0
Generic placeholder image

Current Functional Foods

Editor-in-Chief

ISSN (Print): 2666-8629
ISSN (Online): 2666-8637

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Review Article

Hand-in-glove Effect of Piperine in Anti-cancer Formulations

Author(s): Jatin Kumar, Priyanka Kriplani* and Kumar Guarve

Volume 2, Issue 2, 2024

Published on: 25 September, 2023

Article ID: e270723219193 Pages: 17

DOI: 10.2174/2666862901666230727104158

Price: $65

Abstract

Background: Piperine, an active constituent isolated from Piper nigrum, Piper chaba, Piper sarmentosum, Piper guineense and Piper longum which is used to cure a variety of ailments related to lung, stomach, colon, skin etc. like Alzheimer’s, Parkinson’s disease, ulcerative colitis, cancer, arthritis, inflammatory bowel diseases, diabetes etc.

Objective: The objective of the review is to study the synergistic effect of piperine specially in cancer.

Methods: Patents and current literature mainly emphasizing the synergistic effect of piperine along with other drugs, especially anticancer drugs was reviewed keeping in mind the scientific novelty and impact.

Results: Several synergistic combinations of piperine were explored which can be beneficial for the pharmaceutical industry.

Conclusion: This review will assist the researchers in the preparation of novel formulations with improved efficacy cutting the cost of developing new drug molecules.

Graphical Abstract

[1]
Keith CT, Borisy AA, Stockwell BR. Multicomponent therapeutics for networked systems. Nat Rev Drug Discov 2005; 4(1): 71-8.
[http://dx.doi.org/10.1038/nrd1609] [PMID: 15688074]
[2]
Foucquier J, Guedj M. Analysis of drug combinations: Current methodological landscape. Pharmacol Res Perspect 2015; 3(3): e00149.
[http://dx.doi.org/10.1002/prp2.149] [PMID: 26171228]
[3]
Podolsky SH, Greene JA. Combination drugs--hype, harm, and hope. N Engl J Med 2011; 365(6): 488-91.
[http://dx.doi.org/10.1056/NEJMp1106161] [PMID: 21830965]
[4]
Mok TSK, Kim SW, Wu YL, et al. Gefitinib plus chemotherapy versus chemotherapy in epidermal growth factor receptor mutation–positive non–small-cell lung cancer resistant to first-line gefitinib (impress): Overall survival and biomarker analyses. J Clin Oncol 2017; 35(36): 4027-34.
[http://dx.doi.org/10.1200/JCO.2017.73.9250] [PMID: 28968167]
[5]
Yang JCH, Mok T, Han B, Orlando M, Puri T, Park K. A review of regimens combining pemetrexed with an epidermal growth factor receptor tyrosine kinase inhibitor in the treatment of advanced nonsquamous Non-Small-Cell Lung cancer. Clin Lung Cancer 2018; 19(1): 27-34.
[http://dx.doi.org/10.1016/j.cllc.2017.06.013] [PMID: 28743421]
[6]
García-Fuente A, Vázquez F, Viéitez JM, García Alonso FJ, Martín JI, Ferrer J. CISNE: An accurate description of dose-effect and synergism in combination therapies. Sci Rep 2018; 8(1): 4964.
[http://dx.doi.org/10.1038/s41598-018-23321-6] [PMID: 29563526]
[7]
Tiwari A, Mahadik KR, Gabhe SY. Piperine: A comprehensive review of methods of isolation, purification and biological properties. Med. in Drug Dis 2020; p. 100027.
[8]
Shanxi Huatai Pharmaceutical Co Ltd. Extraction method and application of piperine. Patent CN 103483309A, 2017., 2017.
[9]
Patron A, Nonkowicz J, Anger T, Davis JR, Fordsin C, Prester C. Compounds useful as TRPM8 modulators. patent CN108473484B, 2021., 2021.
[10]
Qazi GN, Bedi LA, Johri KR, et al. Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof. Patent US7514105B2, 2006.
[11]
Haq IU, Imran M, Nadeem M, Tufail T, Gondal TA, Mubarak MS. Piperine: A review of its biological effects. Phytother Res 2021; 35(2): 680-700.
[http://dx.doi.org/10.1002/ptr.6855] [PMID: 32929825]
[12]
Gorgani L, Mohammadi M, Najafpour GD, Nikzad M. Piperine-The bioactive compound of black pepper: From isolation to medicinal formulations. Compr Rev Food Sci Food Saf 2017; 16(1): 124-40.
[http://dx.doi.org/10.1111/1541-4337.12246] [PMID: 33371546]
[13]
Rather RA, Bhagat M. Cancer chemoprevention and piperine: Molecular mechanisms and therapeutic opportunities. Front Cell Dev Biol 2018; 6: 10.
[http://dx.doi.org/10.3389/fcell.2018.00010] [PMID: 29497610]
[14]
Motiwala MN, Rangari VD. combined effect of paclitaxel and piperine on a MCF-7 breast cancer cell line in vitro: Evidence of a synergistic interaction. Synres 2015; 1-6.
[15]
Pushpa Ragini S, Naga Divya AV, Anusha CH, Kanthaiah YV. Enhancement of paclitaxel and doxorubicin cytotoxicity in breast cancer cell lines in combination with piperine treatment and analysis of expression of autography and apoptosis genes. J Med Sci Res 2014; 2: 62-7.
[16]
Talib W. Regressions of breast carcinoma syngraft following treatment with piperine in combination with thymoquinone. Sci Pharm 2017; 85(3): 27.
[http://dx.doi.org/10.3390/scipharm85030027] [PMID: 28671634]
[17]
Stojanovic Z, Pejcic M, Aleksic A, Kumar A. Piperine-a major principle of black pepper: A review of its bioactivity and studies. App Sci 2019; 9: 4270.
[http://dx.doi.org/10.3390/app9204270]
[18]
Min X, Jia L, Haoyang Y, Junqi W. 4, 5-disubstituted piperine derivatives, and preparation method and application thereof. Patent CN111592520A,, 2020.
[19]
Wang YH, Morris-Natschke SL, Yang J, Niu HM, Long CL, Lee KH. Anticancer principles from medicinal piper (hú jiāo) plants. J Tradit Complement Med 2014; 4(1): 8-16.
[http://dx.doi.org/10.4103/2225-4110.124811] [PMID: 24872928]
[20]
Bhardwaj RK, Glaeser H, Becquemont L, Klotz U, Gupta SK, Fromm MF. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J Pharmacol Exp Ther 2002; 302(2): 645-50.
[http://dx.doi.org/10.1124/jpet.102.034728] [PMID: 12130727]
[21]
Manayi A, Nabavi SM, Setzer WN, Jafari S. Piperine as a potential anti-cancer agent: A review on preclinical studies. Curr Med Chem 2019; 25(37): 4918-28.
[http://dx.doi.org/10.2174/0929867324666170523120656 ] [PMID: 28545378]
[22]
Thiel A, Buskens C, Woehrle T, et al. Black pepper constituent piperine: Genotoxicity studies in vitro and in vivo. Food Chem Toxicol 2014; 66: 350-7.
[http://dx.doi.org/10.1016/j.fct.2014.01.056] [PMID: 24525095]
[23]
Yue G, Yuguang W, Donghua H, et al. Novel medicinal application of piperine. Patent CN103690537A, 2014.
[24]
Arlert A, Kruger A, Rage C, Pizzar R. Use of piperine and its derivatives for the treatment of neurological conditions. Patent JP2010531857A, 2010.
[25]
Chavarria D, Silva T, Magalhães e Silva D, Remião F, Borges F. Lessons from black pepper: Piperine and derivatives thereof. Expert Opin Pat 2016; 26: 245-64.
[26]
Chinta G, Syed BS, Coumar SM, Periyasamy L. Piperine: A comprehensive review of preclinical and clinical investigations. Curr Bioact Compd 2015; 11(3): 156-69.
[http://dx.doi.org/10.2174/1573407211666150915214425]
[27]
Li N, Wen S, Chen G, Wang S. Antiproliferative potential of piperine and curcumin in drug-resistant human leukemia cancer cells are mediated via autophagy and apoptosis induction, s-phase cell cycle arrest and inhibition of cell invasion and migration. J BUON 2020; 25(1): 401-6.
[PMID: 32277661]
[28]
Tripathi AK, Ray AK, Mishra SK. Molecular and pharmacological aspects of piperine as a potential molecule for disease prevention and management: Evidence from clinical trials. Beni Suef Univ J Basic Appl Sci 2022; 11(1): 16.
[http://dx.doi.org/10.1186/s43088-022-00196-1] [PMID: 35127957]
[29]
Selvaraj J, Anita M, Jayamathi G, et al. Molecular docking analysis of piperine with cdk2, cdk4, cyclin d and cyclin t proteins. Bioinformation 2020; 16(5): 359-62.
[http://dx.doi.org/10.6026/97320630016359] [PMID: 32831516]
[30]
Grinevicius VMAS, Andrade KS, Mota NSRS, et al. CDK2 and Bcl-xL inhibitory mechanisms by docking simulations and anti-tumor activity from piperine enriched supercritical extract. Food Chem Toxicol 2019; 132: 110644.
[http://dx.doi.org/10.1016/j.fct.2019.110644] [PMID: 31252023]
[31]
Choi Y, Yu AM. ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development. Curr Pharm Des 2014; 20(5): 793-807.
[http://dx.doi.org/10.2174/138161282005140214165212 ] [PMID: 23688078]
[32]
Gameiro M, Silva R, Rocha-Pereira C, et al. Cellular models and in vitro assays for the screening of modulators of P-gp, MRP1 and BCRP. Molecules 2017; 22(4): 600.
[http://dx.doi.org/10.3390/molecules22040600] [PMID: 28397762]
[33]
Li S, Lei Y, Jia Y, Li N, Wink M, Ma Y. Piperine, a piperidine alkaloid from piper nigrum re-sensitizes p-gp, mrp1 and bcrp dependent multidrug resistant cancer cells. Phytomedicine 2011; 19(1): 83-7.
[http://dx.doi.org/10.1016/j.phymed.2011.06.031] [PMID: 21802927]
[34]
Syed SB, Arya H, Fu IH, et al. Targeting P-glycoprotein: Investigation of piperine analogs for overcoming drug resistance in cancer. Sci Rep 2017; 7(1): 7972.
[http://dx.doi.org/10.1038/s41598-017-08062-2] [PMID: 28801675]
[35]
George K, Thomas NS, Malathi R. Piperine blocks voltage gated K+ current and inhibits proliferation in androgen sensitive and insensitive human prostate cancer cell lines. Arch Biochem Biophys 2019; 667: 36-48.
[http://dx.doi.org/10.1016/j.abb.2019.04.007] [PMID: 31047869]
[36]
Zeng Y, Yang Y. Piperine depresses the migration progression via downregulating the Akt/mTOR/MMP 9 signaling pathway in DU145 cells. Mol Med Rep 2018; 17(5): 6363-70.
[http://dx.doi.org/10.3892/mmr.2018.8653] [PMID: 29488612]
[37]
Mihaylova MM, Shaw RJ. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 2011; 13(9): 1016-23.
[http://dx.doi.org/10.1038/ncb2329] [PMID: 21892142]
[38]
Peng X, Yang T, Liu G, Liu H, Peng Y, He L. Piperine ameliorated lupus nephritis by targeting AMPK-mediated activation of NLRP3 inflammasome. Int Immunopharmacol 2018; 65: 448-57.
[http://dx.doi.org/10.1016/j.intimp.2018.10.025] [PMID: 30388519]
[39]
Sadri Nahand J, Bokharaei-Salim F, Salmaninejad A, et al. microRNAs: Key players in virus‐associated hepatocellular carcinoma. J Cell Physiol 2019; 234(8): 12188-225.
[http://dx.doi.org/10.1002/jcp.27956] [PMID: 30536673]
[40]
Yang R, Gao N, Chang Q, Meng X, Wang W. The role of IDO, IL‐10, and TGF‐β in the HCV‐associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. J Med Virol 2019; 91(2): 265-71.
[http://dx.doi.org/10.1002/jmv.25083] [PMID: 29611873]
[41]
Huang H. Matrix metalloproteinase-9 (MMP-9) as a cancer biomarker and MMP-9 biosensors: Recent advances. Sensors 2018; 18(10): 3249.
[http://dx.doi.org/10.3390/s18103249] [PMID: 30262739]
[42]
Hwang YP, Yun HJ, Kim HG, et al. Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by piperine via the inhibition of PKCα/ERK1/2-dependent matrix metalloproteinase-9 expression. Toxicol Lett 2011; 203(1): 9-19.
[http://dx.doi.org/10.1016/j.toxlet.2011.02.013] [PMID: 21354279]
[43]
Janani C, Ranjitha Kumari BD. PPAR gamma gene – A review. Diabetes Metab Syndr 2015; 9(1): 46-50.
[http://dx.doi.org/10.1016/j.dsx.2014.09.015] [PMID: 25450819]
[44]
Park UH, Jeong HS, Jo EY, et al. Piperine, a component of black pepper, inhibits adipogenesis by antagonizing PPARγ activity in 3T3-L1 cells. J Agric Food Chem 2012; 60(15): 3853-60.
[http://dx.doi.org/10.1021/jf204514a] [PMID: 22463744]
[45]
Pradeep CR, Kuttan G. Piperine is a potent inhibitor of nuclear factor-κB (NF-κB), c-Fos, CREB, ATF-2 and proinflammatory cytokine gene expression in B16F-10 melanoma cells. Int Immunopharmacol 2004; 4(14): 1795-803.
[http://dx.doi.org/10.1016/j.intimp.2004.08.005] [PMID: 15531295]
[46]
Ren C, Liang Z. RETRACTED: Piperine alleviates lipopolysaccharide-induced inflammatory injury by down-regulating microRNA-127 in murine chondrogenic ATDC5 cells. Biomed Pharmacother 2018; 103: 947-54.
[http://dx.doi.org/10.1016/j.biopha.2018.04.108] [PMID: 29710511]
[47]
Si L, Yang R, Lin R, Yang S. Piperine functions as a tumor suppressor for human ovarian tumor growth via activation of JNK/p38 MAPK-mediated intrinsic apoptotic pathway. Biosci Rep 2018; 38(3): BSR20180503.
[http://dx.doi.org/10.1042/BSR20180503] [PMID: 29717031]
[48]
Tawani A, Amanullah A, Mishra A, Kumar A. Evidences for Piperine inhibiting cancer by targeting human G-quadruplex DNA sequences. Sci Rep 2016; 6(1): 39239.
[http://dx.doi.org/10.1038/srep39239 ] [PMID: 27995955]
[49]
de Almeida GC, Oliveira LFS, Predes D, et al. Piperine suppresses the Wnt/β-catenin pathway and has anti-cancer effects on colorectal cancer cells. Sci Rep 2020; 10(1): 11681.
[http://dx.doi.org/10.1038/s41598-020-68574-2]
[50]
Khamis AAA, Ali EMM. EL-Moneim MAA, Abd-Alhaseeb MM, EL-Magd MA, Salim EI. Hesperdine, piperine and bee venom synergistically potentiate the anticancer effect of tamoxifen against breast cancer cells. Biomed Pharmacother 2018; 105: 1335-43.
[http://dx.doi.org/10.1016/j.biopha.2018.06.105] [PMID: 30021371]
[51]
Kumar V, Mittal V, Jalwal P. Role of herbal bioenhancers (Piperine and Curcumin) on the oral bioavailability of Tamoxifen using experimental rats. J Pharmacogn Phytochem 2015; 4(2): 133-6.
[52]
Katiyar SS, Muntimadugu E, Rafeeqi TA, Domb AJ, Khan W. Co-delivery of rapamycin: And piperine-loaded polymeric nanoparticles for breast cancer treatment. Drug Deliv 2016; 23(7): 2608-16.
[http://dx.doi.org/10.3109/10717544.2015.1039667] [PMID: 26036652]
[53]
Fattah A, Morovati A, Niknam Z, et al. The Synergistic combination of cisplatin and piperine induces apoptosis in MCF-7 cell line. Iran J Public Health 2021; 50(5): 1037-47.
[http://dx.doi.org/10.18502/ijph.v50i5.6121] [PMID: 34183962]
[54]
Burande AS, Viswanadh MK, Jha A, et al. EGFR targeted paclitaxel and piperine co-loaded liposomes for the treatment of triple negative breast cancer. AAPS PharmSciTech 2020; 21: 1-12.
[55]
Kakarala M, Brenner DE, Korkaya H, et al. Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res Treat 2010; 122(3): 777-85.
[http://dx.doi.org/10.1007/s10549-009-0612-x] [PMID: 19898931]
[56]
Xie Z, Wei Y, Xu J, Lei J, Yu J. Alkaloids from piper nigrum synergistically enhanced the effect of paclitaxel against paclitaxel-resistant cervical cancer cells through the downregulation of Mcl-1. J Agric Food Chem 2019; 67(18): 5159-68.
[http://dx.doi.org/10.1021/acs.jafc.9b01320] [PMID: 31006247]
[57]
Abdelhamed S, Yokoyama S, Refaat A, et al. Piperine enhances the efficacy of TRAIL-based therapy for triple-negative breast cancer cells. Anticancer Res 2014; 34(4): 1893-9.
[PMID: 24692724]
[58]
Jeong S, Jung S, Park GS, Shin J, Oh JW. Piperine synergistically enhances the effect of temozolomide against temozolomide-resistant human glioma cell lines. Bioengineered 2020; 11(1): 791-800.
[http://dx.doi.org/10.1080/21655979.2020.1794100] [PMID: 32693671]
[59]
Singh A, Thotakura N, Singh B, et al. Delivery of docetaxel to brain employing piperine-tagged PLGA-aspartic acid polymeric micelles: Improved cytotoxic and pharmacokinetic profiles. AAPS PharmSciTech 2019; 20(6): 220.
[http://dx.doi.org/10.1208/s12249-019-1426-8] [PMID: 31201588]
[60]
Srivastava S, Dewangan J, Mishra S, et al. Piperine and celecoxib synergistically inhibit colon cancer cell proliferation via modulating wnt/β-catenin signaling pathway. Phytomedicine 2021; 84: 153484.
[http://dx.doi.org/10.1016/j.phymed.2021.153484] [PMID: 33667839]
[61]
Bolat ZB, Islek Z, Demir BN, Yilmaz EN, Sahin F, Ucisik MH. Curcumin- and piperine-loaded emulsomes as combinational treatment approach enhance the anticancer activity of curcumin on hct116 colorectal cancer model. Front Bioeng Biotechnol 2020; 8: 50.
[http://dx.doi.org/10.3389/fbioe.2020.00050] [PMID: 32117930]
[62]
Lambert JD, Hong J, Kim DH, Mishin VM, Yang CS. Piperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3-gallate in mice. J Nutr 2004; 134(8): 1948-52.
[http://dx.doi.org/10.1093/jn/134.8.1948] [PMID: 15284381]
[63]
Das S, Bera D, Pal K, et al. Guar gum micro-vehicle mediated delivery strategy and synergistic activity of thymoquinone and piperine: An in vitro study on bacterial and hepatocellular carcinoma cells. J Drug Deliv Sci Technol 2020; 60: 101994.
[http://dx.doi.org/10.1016/j.jddst.2020.101994]
[64]
Pal MK, Jaiswar SP, Srivastav AK, et al. Synergistic effect of piperine and paclitaxel on cell fate via cyt-c, Bax/Bcl-2-caspase-3 pathway in ovarian adenocarcinomas SKOV-3 cells. Eur J Pharmacol 2016; 791: 751-62.
[http://dx.doi.org/10.1016/j.ejphar.2016.10.019] [PMID: 27756602]
[65]
Qiu M, Xue C, Zhang L. Piperine alkaloid induces anticancer and apoptotic effects in cisplatin resistant ovarian carcinoma by inducing G2/M phase cell cycle arrest, caspase activation and inhibition of cell migration and PI3K/Akt/GSK3β signalling pathway. J BUON 2019; 24(6): 2316-21.
[PMID: 31983100]
[66]
Ding Y, Ding Y, Wang Y, et al. Soluplus ®/TPGS mixed micelles for co-delivery of docetaxel and piperine for combination cancer therapy. Pharm Dev Technol 2020; 25(1): 107-15.
[http://dx.doi.org/10.1080/10837450.2019.1679834] [PMID: 31603017]
[67]
Biswas S, Kar A, Sharma N, Haldar PK, Mukherjee PK. Synergistic effect of ursolic acid and piperine in CCl 4 induced hepatotoxicity. Ann Med 2021; 53(1): 2009-17.
[http://dx.doi.org/10.1080/07853890.2021.1995625] [PMID: 34751064]
[68]
Makhov P, Golovine K, Canter D, et al. Co-administration of piperine and docetaxel results in improved anti-tumor efficacy via inhibition of CYP3A4 activity. Prostate 2012; 72(6): 661-7.
[http://dx.doi.org/10.1002/pros.21469] [PMID: 21796656]
[69]
Li C, Wang Z, Wang Q, et al. Enhanced anti-tumor efficacy and mechanisms associated with docetaxel-piperine combination- in vitro and in vivo investigation using a taxane-resistant prostate cancer model. Oncotarget 2018; 9(3): 3338-52.
[http://dx.doi.org/10.18632/oncotarget.23235] [PMID: 29423050]
[70]
Ba Y, Malhotra A. Potential of piperine in modulation of voltage-gated K+ current and its influences on cell cycle arrest and apoptosis in human prostate cancer cells. Eur Rev Med Pharmacol Sci 2018; 22(24): 8999-9011.
[PMID: 30575945]
[71]
So EC, Wu SN, Wu PC, Chen HZ, Yang CJ. Synergistic inhibition of delayed rectifier k+ and voltage-gated na+ currents by artemisinin in pituitary tumor (gh3) cells. Cell Physiol Biochem 2017; 41(5): 2053-66.
[http://dx.doi.org/10.1159/000475436] [PMID: 28456794]
[72]
Mhaske DB, Sreedharan S, Mahadik KR. Role of piperine as an effective bioenhancer in drug absorption. Pharm Anal Acta 2018; 9(7): 1-4.
[73]
Berman AY, Motechin RA, Wiesenfeld MY, Holz MK. The therapeutic potential of resveratrol: A review of clinical trials. NPJ Precis Oncol 2017; 1(1): 35.
[http://dx.doi.org/10.1038/s41698-017-0038-6] [PMID: 28989978]
[74]
Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies. Anticancer Res 2004; 24(5A): 2783-840.
[PMID: 15517885]
[75]
Johnson JJ, Nihal M, Siddiqui IA, et al. Enhancing the bioavailability of resveratrol by combining it with piperine. Mol Nutr Food Res 2011; 55(8): 1169-76.
[http://dx.doi.org/10.1002/mnfr.201100117] [PMID: 21714124]
[76]
Patil UK, Singh A, Chakraborty AK. Role of piperine as a bioavailability enhancer. Int J Recent Adv Pharm Res 2011; 4: 16-23.
[77]
Thammineni N, Vara Lakshmi M, Nandaki Nag K, et al. Studying whether curcumin and piperine sensitize breast cancer cells and breast cancer- initiating cells to radiations. Int J Radiat Oncol Biol Phys 2014; 90(1): S246.
[http://dx.doi.org/10.1016/j.ijrobp.2014.05.868]
[78]
Guo L, Yang Y, Sheng Y, Wang J, Ruan S, Han C. Mechanism of piperine in affecting apoptosis and proliferation of gastric cancer cells via ROS‐mitochondria‐associated signalling pathway. J Cell Mol Med 2021; 25(20): 9513-22.
[http://dx.doi.org/10.1111/jcmm.16891] [PMID: 34464498]
[79]
Hsu SC, Chung JG. Anticancer potential of emodin. Biomedicine 2012; 2(3): 108-16.
[http://dx.doi.org/10.1016/j.biomed.2012.03.003] [PMID: 32289000]
[80]
Di X, Wang X, Di X, Liu Y. Effect of piperine on the bioavailability and pharmacokinetics of emodin in rats. J Pharm Biomed Anal 2015; 115: 144-9.
[http://dx.doi.org/10.1016/j.jpba.2015.06.027 ] [PMID: 26201645]
[81]
Li H, Krstin S, Wang S, Wink M. Capsaicin and piperine can overcome multidrug resistance in cancer cells to doxorubicin. Molecules 2018; 23(3): 557.
[http://dx.doi.org/10.3390/molecules23030557] [PMID: 29498663]
[82]
Gewirtz D. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 1999; 57(7): 727-41.
[http://dx.doi.org/10.1016/S0006-2952(98)00307-4 ] [PMID: 10075079]
[83]
Fofaria NM, Kim SH, Srivastava SK. Piperine causes G1 phase cell cycle arrest and apoptosis in melanoma cells through checkpoint kinase-1 activation. PLoS One 2014; 9(5): e94298.
[http://dx.doi.org/10.1371/journal.pone.0094298] [PMID: 24804719]
[84]
Kapinova A, Stefanicka P, Kubatka P, et al. Are plant-based functional foods better choices against cancer than single phytochemicals? A critical review of current breast cancer research. Biomed Pharmacother 2017; 95: 1465-77.
[http://dx.doi.org/10.1016/j.biopha.2017.11.134] [PMID: 29198744]
[85]
Neyrinck AM, Alligier M, Memvanga PB, et al. Curcuma longa extract associated with white pepper lessens high fat diet-induced inflammation in subcutaneous adipose tissue. PLoS One 2013; 8(11): e81252.
[http://dx.doi.org/10.1371/journal.pone.0081252] [PMID: 24260564]
[86]
Rathee D, Kamboj A, Sidhu S. Augmentation of hepatoprotective potential of aegle marmelos in combination with piperine in carbon tetrachloride model in wistar rats. Chem Cent J 2018; 12(1): 94.
[http://dx.doi.org/10.1186/s13065-018-0463-9] [PMID: 30123925]
[87]
Ying X, Chen X, Cheng S, Shen Y, Peng L, Xu H. Piperine inhibits IL-β induced expression of inflammatory mediators in human osteoarthritis chondrocyte. Int Immunopharmacol 2013; 17(2): 293-9.
[http://dx.doi.org/10.1016/j.intimp.2013.06.025] [PMID: 23838114]
[88]
Abdel-Daim MM, Sayed AA, Abdeen A, et al. Piperine enhances the antioxidant and anti-inflammatory activities of thymoquinone against microcystin-l rinduced hepatotoxicity and neurotoxicity in mice. Oxid Med Cell Longev 2019; 2019: 1-10.
[http://dx.doi.org/10.1155/2019/1309175] [PMID: 31178949]
[89]
Khatri S, Awasthi R. Piperine containing floating microspheres: An approach for drug targeting to the upper gastrointestinal tract. Drug Deliv Transl Res 2016; 6(3): 299-307.
[http://dx.doi.org/10.1007/s13346-016-0285-z ] [PMID: 26902907]
[90]
Hiwale AR, Dhuley JN, Naik SR. Effect of co-administration of piperine on pharmacokinetics of beta-lactam antibiotics in rats. Indian J Exp Biol 2002; 40(3): 277-81.
[PMID: 12635696]
[91]
Janakiraman K, Manavalan R. Studies on effect of piperine on oral bioavailability of ampicillin and norfloxacin. Afr J Tradit Complement Altern Med 2008; 5(3): 257-62.
[http://dx.doi.org/10.4314/ajtcam.v5i3.31281]
[92]
Panahi Y, Khalili N, Hosseini MS, Abbasinazari M, Sahebkar A. Lipid-modifying effects of adjunctive therapy with curcuminoids–piperine combination in patients with metabolic syndrome: Results of a randomized controlled trial. Complement Ther Med 2014; 22(5): 851-7.
[http://dx.doi.org/10.1016/j.ctim.2014.07.006] [PMID: 25440375]
[93]
Singh S, Kumar P. Piperine in combination with quercetin halt 6-OHDA induced neurodegeneration in experimental rats: Biochemical and neurochemical evidences. Neurosci Res 2018; 133: 38-47.
[http://dx.doi.org/10.1016/j.neures.2017.10.006] [PMID: 29056550]
[94]
Singh S, Kumar P. Neuroprotective activity of curcumin in combination with piperine against quinolinic acid induced neurodegeneration in rats. Pharmacology 2016; 97(3-4): 151-60.
[http://dx.doi.org/10.1159/000443896] [PMID: 26828892]
[95]
Wardlaw JM, Murray V, Berge E, et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: An updated systematic review and meta-analysis. Lancet 2012; 379(9834): 2364-72.
[http://dx.doi.org/10.1016/S0140-6736(12)60738-7 ] [PMID: 22632907]
[96]
Strimpakos AS, Sharma RA. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal 2008; 10(3): 511-46.
[http://dx.doi.org/10.1089/ars.2007.1769 ] [PMID: 18370854]
[97]
Abdul Manap AS, Tan Wei AC, Leong WH, et al. Synergistic effects of curcumin and piperine as potent acetylcholine and amyloidogenic inhibitors with significant neuroprotective activity in sh-sy5y cells via computational molecular modeling and in vitro assay. front. Aging Neurosci 2019; 27: 11-206.
[98]
Balakrishnan V, Varma S, Chatterji D. Piperine augments transcription inhibitory activity of rifampicin by severalfold in mycobacterium smegmatis. Curr Sci 2001; 80(10): 1302-5.
[99]
Patel S, Devada S, Patel H, Patel N, Bhavsar S, Thaker A. Influence of co-administration of piperine on pharmacokinetic profile of gatifloxacin in layer birds. Glob Vet 2011; 7(5): 427-32.
[100]
Junsaeng D, Anukunwithaya T, Songvut P, Sritularak B, Likhitwitayawuid K, Khemawoot P. Comparative pharmacokinetics of oxyresveratrol alone and in combination with piperine as a bioenhancer in rats. BMC Complement Altern Med 2019; 19(1): 235.
[http://dx.doi.org/10.1186/s12906-019-2653-y] [PMID: 31477089]
[101]
Krstin S, Peixoto HS, Wink M. Combinations of alkaloids affecting different molecular targets with the saponin digitonin can synergistically enhance trypanocidal activity against trypanosoma brucei brucei. Antimicrob Agents Chemother 2015; 59(11): 7011-7.
[http://dx.doi.org/10.1128/AAC.01315-15] [PMID: 26349826]
[102]
Rinwa P, Kumar A. Piperine potentiates the protective effects of curcumin against chronic unpredictable stress-induced cognitive impairment and oxidative damage in mice. Brain Res 2012; 1488(1488): 38-50.
[http://dx.doi.org/10.1016/j.brainres.2012.10.002] [PMID: 23099054]
[103]
Moorthi C, Krishnan K, Manavalan R, Kathiresan K. Preparation and characterization of curcumin–piperine dual drug loaded nanoparticles. Asian Pac J Trop Biomed 2012; 2(11): 841-8.
[http://dx.doi.org/10.1016/S2221-1691(12)60241-X] [PMID: 23569859]
[104]
Tu YS, Fu JW, Sun DM, et al. Preparation, characterisation and evaluation of curcumin with piperine-loaded cubosome nanoparticles. J Microencapsul 2014; 31(6): 551-9.
[http://dx.doi.org/10.3109/02652048.2014.885607] [PMID: 24641575]
[105]
Mgbeahuruike EE, Stalnacke M, Vuorela H, Holm Y. Antimicrobial and synergistic effects of commercial piperine and piper longum in combination with conventional antimicrobials. Antibiotics 2019; 8(2): 55.
[106]
Tokam Kuaté CR, Bisso Ndezo B, Dzoyem JP. Synergistic antibiofilm effect of thymol and piperine in combination with aminoglycosides antibiotics against four salmonella enterica serovars. Evid Based Complement Alternat Med 2021; 1567017.
[http://dx.doi.org/10.1155/2021/1567017]
[107]
Athukuri BL, Neerati P. Enhanced oral bioavailability of domperidone with piperine in male wistar rats: involvement of CYP3A1 and P-gp inhibition. J Pharm Pharm Sci 2017; 20: 28-37.
[http://dx.doi.org/10.18433/J3MK72] [PMID: 28459658]
[108]
Pattanaik S, Hota D, Prabhakar S, Kharbanda P, Pandhi P. Effect of piperine on the steady-state pharmacokinetics of phenytoin in patients with epilepsy. phyther res. an int. j. devoted to pharmacol toxicol eval. Nat Prod Deriv 2006; 20: 683-6.
[109]
Auti P, Choudhary A, Gabhe S, Mahadik K. Bioanalytical method development, validation and its application in pharmacokinetic studies of verapamil in the presence of piperine in rats. Int J Pharm Res 2018; 10: 119.
[110]
Bano G, Amla V, Raina R, Zutshi U, Chopra C. The effect of piperine on pharmacokinetics of phenytoin in healthy volunteers. Planta Med 1987; 53(6): 568-9.
[http://dx.doi.org/10.1055/s-2006-962814] [PMID: 3444866]
[111]
Bedada SK, Boga PK. The influence of piperine on the pharmacokinetics of fexofenadine, a P-glycoprotein substrate, in healthy volunteers. Eur J Clin Pharmacol 2017; 73(3): 343-9.
[http://dx.doi.org/10.1007/s00228-016-2173-3] [PMID: 27981349]
[112]
Auti P, Gabhe S, Mahadik K. Pharmacokinetic studies of secnidazole in the presence of piperine and its synthetic derivative. Int J Pharm Sci Res 2018; 1455-61.
[113]
Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas P. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 1998; 64(4): 353-6.
[http://dx.doi.org/10.1055/s-2006-957450] [PMID: 9619120]
[114]
Bano G, Raina RK, Zutshi U, Bedi KL, Johri RK, Sharma SC. Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers. Eur J Clin Pharmacol 1991; 41(6): 615-7.
[http://dx.doi.org/10.1007/BF00314996] [PMID: 1815977]
[115]
Bisso Ndezo B, Tokam Kuaté CR, Dzoyem JP. Synergistic antibiofilm efficacy of thymol and piperine in combination with three aminoglycoside antibiotics against klebsiella pneumoniae biofilms. Can J Infect Dis Med Microbiol 2021; 7029944.
[http://dx.doi.org/10.1155/2021/7029944]
[116]
Mohanalakshmi S, Bhatt S, Ashok Kumar CK. Enhanced antihyperlipidemic potential of gemfibrozil under co-administration with piperine. BMC Complement Altern Med 2021; 19(1): 235.
[http://dx.doi.org/10.1016/j.crphar.2021.100021]
[117]
Li G, Ruan L, Chen R, et al. Synergistic antidepressant-like effect of ferulic acid in combination with piperine: Involvement of monoaminergic system. Metab Brain Dis 2015; 30(6): 1505-14.
[http://dx.doi.org/10.1007/s11011-015-9704-y] [PMID: 26220010]
[118]
Hoffman A, Domb JA, Elgart A, Cherniakov I. Formulation and method for increasing oral bioavailability of drugs Patent US20200009067A1, 2020.
[119]
Bhagat U. Optimized nutritional formulations, methods for selection of tailored diets therefrom, and methods of use thereof. Patent CA2814053C, 2012.
[120]
DiMauro MT. Method of topically administering a curcumin derivative. Patent US20160374960A1, 2016.
[121]
Sezgin CV, Bayraktar O. Production of curcumin and piperine loaded double-layered biopolymer based nano delivery systems by using electrospray / coating method. Patent EP3142702B1, 2018.
[122]
Majid M, Badmaev V, Ragendran E. Piperine-containing composition. Patent JP3953513B2, 2007.
[123]
Jingling T, Jinmei R, Linhua W, Hongyu J, Mengting L, Chao C. Carry solid lipid nanoparticle of curcumin and piperine and preparation method thereof. Patent CN103784421B, 2016.
[124]
Kapil Singh R. Pharmaceutical compositions containing piperine and an antituberculosis or antileprosydrug. Patent EP0650728, 1995.
[125]
Patel BR, Modi AI. Compositions containing piperine. Patent US5616593,, 1997.
[126]
Khajuria A, Thusu N, Zutshi U. Piperine modulates permeability characteristics of intestine by inducing alterations in membrane dynamics: Influence on brush border membrane fluidity, ultrastructure and enzyme kinetics. Phytomedicine 2002; 9(3): 224-31.
[http://dx.doi.org/10.1078/0944-7113-00114 ] [PMID: 12046863]
[127]
Veerareddy PR, Vobalaboina V. Pharmacokinetics and tissue distribution of piperine lipid nanospheres. Pharmazie 2008; 63(5): 352-5.
[PMID: 18557418]
[128]
Kaur J, Singh RR, Khan E, Kumar A, Joshi A. Piperine-loaded PLGA nanoparticles as cancer drug carriers. ACS Appl Nano Mater 2021; 4(12): 14197-207.
[http://dx.doi.org/10.1021/acsanm.1c03664]
[129]
AbouAitah K, Stefanek A, Higazy IM, et al. Effective targeting of colon cancer cells with piperine natural anticancer prodrug using functionalized clusters of hydroxyapatite nanoparticles. Pharmaceutics 2020; 12(1): 70.
[http://dx.doi.org/10.3390/pharmaceutics12010070 ] [PMID: 31963155]
[130]
Guldiken B, Ozkan G, Catalkaya G, Ceylan FD, Ekin Yalcinkaya I, Capanoglu E. Phytochemicals of herbs and spices: Health versus toxicological effects. Food Chem Toxicol 2018; 119: 37-49.
[http://dx.doi.org/10.1016/j.fct.2018.05.050] [PMID: 29802945]
[131]
Piyachaturawat P, Glinsukon T, Toskulkao C. Acute and subacute toxicity of piperine in mice, rats and hamsters. Toxicol Lett 1983; 16(3-4): 351-9.
[http://dx.doi.org/10.1016/0378-4274(83)90198-4] [PMID: 6857729]
[132]
Chonpathompikunlert P, Yoshitomi T, Han J, Isoda H, Nagasaki Y. The use of nitroxide radical-containing nanoparticles coupled with piperine to protect neuroblastoma SH-SY5Y cells from Aβ-induced oxidative stress. Biomaterials 2011; 32(33): 8605-12.
[http://dx.doi.org/10.1016/j.biomaterials.2011.07.024 ] [PMID: 21855995]
[133]
Daware M, Mujumdar A, Ghaskadbi S. Reproductive toxicity of piperine in Swiss albino mice. Planta Med 2000; 66(3): 231-6.
[http://dx.doi.org/10.1055/s-2000-8560] [PMID: 10821048]
[134]
Kazmi I, Al-Abbasi FA, Imam SS, et al. Formulation of piperine nanoparticles: In vitro breast cancer cell line and in vivo evaluation. Polymers 2022; 14(7): 1349.
[http://dx.doi.org/10.3390/polym14071349] [PMID: 35406223]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy